World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
14061
World Ranking
3690
National Ranking
37

Reinhard Kirnbauer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Reinhard Kirnbauer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 139 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Reinhard Kirnbauer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Reinhard Kirnbauer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Reinhard Kirnbauer is affiliated with the Medical University of Vienna in Austria. Their research primarily focuses on medicine, with significant contributions in immunology and microbiology, as well as biochemistry, genetics, and molecular biology. Their work spans several subfields including epidemiology, immunology, molecular biology, surgery, and cancer research.

The main topics addressed by Kirnbauer include cervical cancer and HPV research, immunotherapy and immune responses, immune response and inflammation, virus-based gene therapy research, herpesvirus infections and treatments, RNA interference and gene delivery, and colorectal and anal carcinomas.

The scientist has published in a range of scientific journals, notably the following venues:

  • Vaccine
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Cancer Discovery
  • Journal of Clinical Medicine
  • Journal of Virology

Some recent papers authored or co-authored by Kirnbauer include:

  • RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates (2021, Journal of Clinical Medicine)
  • Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers (2022, Cancer Discovery)
  • Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists (2020, Vaccine)
  • RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer (2022, Journal of Virology)
  • Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development (2022, Frontiers in Immunology)

Frequent co-authors collaborating with Kirnbauer include:

  • Richard B.S. Roden
  • Bettina Huber
  • Lígia A. Pinto
  • Robert H. Shoemaker
  • Jason D. Marshall

Best Publications

  • Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

    R Kirnbauer;F Booy;N Cheng;D R Lowy

  • Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

    A Köck;T Schwarz;R Kirnbauer;A Urbanski

  • Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

    Reinhard Kirnbauer;Janet Taub;Heather Greenstone;Richard Roden

  • Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

    F Breitburd;R Kirnbauer;N L Hubbert;B Nonnenmacher

  • Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

    Heather L. Greenstone;John D. Nieland;Karin E. de Visser;Marloes L. H. De Bruijn

  • A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

    Reinhard Kirnbauer;Nancy L. Hubbert;Cosette M. Wheeler;Thomas M. Becker

  • Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization

    R. Kirnbauer;L.M. Chandrachud;B.W. O'neil;E.R. Wagner

  • In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

    Richard B.S. Roden;Heather L. Greenstone;Reinhard Kirnbauer;Frank P. Booy

  • Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

    Saeed Shafti-Keramat;Alessandra Handisurya;Ernst Kriehuber;Guerrino Meneguzzi

  • Ultraviolet light induces increased circulating interleukin-6 in humans.

    Agatha Urbanski;Thomas Schwarz;Peter Neuner;Jean Krutmann

  • IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

    R Kirnbauer;A Köck;T Schwarz;A Urbanski

  • Genital human papillomavirus infection

    Douglas R. Lowy;Reinhard Kirnbauer;John T. Schiller

  • Cutaneous Human Papillomaviruses Found in Sun-Exposed Skin: Beta-papillomavirus Species 2 Predominates in Squamous Cell Carcinoma

    Ola Forslund;Thomas Iftner;Kristin Andersson;Bernt Lindelöf

  • Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids

    Reinhard Kirnbauer;Andreas Köck;Peter Neuner;Elisabeth Förster

  • Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

    R. B. S. Roden;E. M. Weissinger;D. W. Henderson;F. Booy

  • Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.

    Richard B.S. Roden;Nancy L. Hubbert;Reinhard Kirnbauer;Neil D. Christensen

  • Increased IL-6 Production by Monocytes and Keratinocytes in Patients with Psoriasis

    Peter Neuner;Agatha Urbanski;Franz Trautinger;Annelie Möller

  • Interaction of papillomaviruses with the cell surface.

    R. B. S. Roden;R. Kirnbauer;A. B. Jenson;D. R. Lowy

  • Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

    Matti Lehtinen;Joakim Dillner;Paul Knekt;Tapio Luostarinen

  • High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors.

    Ola Forslund;Bernt Lindelöf;Eva Hradil;Peter Nordin

Frequent Co-Authors

Richard B.S. Roden
Richard B.S. Roden Johns Hopkins University
John T. Schiller
John T. Schiller National Institutes of Health
Thomas Schwarz
Thomas Schwarz Boston Children's Hospital
Douglas R. Lowy
Douglas R. Lowy National Institutes of Health
Matti Lehtinen
Matti Lehtinen Tampere University
Joakim Dillner
Joakim Dillner Karolinska University Hospital
Georg Stingl
Georg Stingl Medical University of Vienna
Neil D. Christensen
Neil D. Christensen Pennsylvania State University
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health
Jean Krutmann
Jean Krutmann Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, branching into healthcare roles such as nurse practitioner specialties can be an excellent way to apply your knowledge in clinical settings. Exploring online pmhnp programs with clinical placement highlights the importance of hands-on training, which is crucial for advancing patient care skills alongside theoretical learning.

Cost is often a deciding factor when choosing a program. Many prospective students look for the cheapest online pmhnp programs to balance education quality with financial feasibility. Affordable options make advanced nursing degrees more accessible, promoting career growth in specialized fields.

Understanding earning potential is also key. The how much does a dnp make resource offers insight into salary expectations by state, helping students make informed decisions about where to study and eventually practice.

For those already in nursing, transitioning roles can expand career prospects. The guide on acute care nurse practitioner programs is valuable for nurses aiming to shift into more specialized, acute care settings, which often require advanced immunology knowledge.

Best Scientists Citing Reinhard Kirnbauer

Trending Scientists

Recently Published Articles